DRUG RECALL - Ondansetron Injection USP used for the Prevention of Nausea/Vomiting During Cancer Treatments and After Surgery
October 1, 2013, Hospira, Inc. has issued a voluntary recall of Ondansetron Injection, USP. The recall was due to a vial defect where particles were found inside of the vials. The two affected lots are 29-484-DK and 29-510-DK with an expiration date of May 1, 2015.
The particles found in the containers were identified as glass strands. If the particles go unnoticed, there is potential for severe injury.
Ondansetron is used to prevent vomiting and nausea during cancer treatments and after surgery.
Although, no adverse health reactions have been associated with this recall, patients in possession of this product are asked to return it to the pharmacy or doctor’s office at which it was obtained. If you have any questions about this recall please contact your local retail pharmacist or speak to your doctor.
For replacement product, please call Stericycle at 1-877-497-3125 Monday through Friday, 8am to 5pm EST.
Adverse events that may be related to the use of this product may also be reported to the United States Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting Program either online, by regular mail, or by fax:
Online - www.fda.gov/medwatch/report.htm
Regular Mail - use postage-paid FDA form 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail the form to: MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787
Fax - 1-800-FDA-0178